Olmesartán/Amlodipino/Hidroclorotiazida Normon (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán/Amlodipino/Hidroclorotiazida Normon, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑component therapy is insufficient. GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipine/Hydrochlorothiazide is used in the management of hypertension, acting on multiple pathways that control blood pressure. - Essential hypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk. - Hypertension with edema: combines vasodilation and diuresis to improve fluid balance. - Hypertension in patients requiring multiple mechanisms: provides angiotensin‑II blockade, calcium‑channel blockade and thiazide‑type diuresis in one tablet.

Side effects may occur with any antihypertensive regimen and should be monitored during therapy.

Common Side Effects: - Dizziness or light‑headedness - Headache - Peripheral edema - Flushing - Fatigue - Increased urination

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Electrolyte disturbances (e.g., low potassium) - Angio‑edema - Liver function abnormalities - Severe skin reactions such as Stevens‑Johnson syndrome

Before prescribing this combination, clinicians should assess patient history and monitor relevant parameters. - Renal function: evaluate creatinine and eGFR before initiation and periodically thereafter. - Electrolytes: check serum potassium and sodium levels, especially when using other diuretics. - Cardiovascular status: monitor for symptomatic hypotension after the first dose. - Pregnancy: contraindicated in the second and third trimesters; avoid use. - Drug hypersensitivity: discontinue if angio‑edema or severe rash develops. - Store at ambient temperature: keep tablets in the original container, protect from moisture and light.

Olmesartan/Amlodipine/Hydrochlorothiazide may interact with several drug classes; clinicians should review patient medication lists.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - NSAIDs (high‑dose or chronic): can blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: may increase lithium levels, risking toxicity. - CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can raise amlodipine concentrations. - Antidiabetic agents: may require dose adjustment due to enhanced glucose‑lowering effect.